Literature DB >> 24686068

Functional antibodies against VAR2CSA in nonpregnant populations from colombia exposed to Plasmodium falciparum and Plasmodium vivax.

Sedami Gnidehou1, Justin Doritchamou, Eliana M Arango, Ana Cabrera, Maria Isabel Arroyo, Kevin C Kain, Nicaise Tuikue Ndam, Amanda Maestre, Stephanie K Yanow.   

Abstract

In pregnancy, parity-dependent immunity is observed in response to placental infection with Plasmodium falciparum. Antibodies recognize the surface antigen, VAR2CSA, expressed on infected red blood cells and inhibit cytoadherence to the placental tissue. In most settings of malaria endemicity, antibodies against VAR2CSA are predominantly observed in multigravid women and infrequently in men, children, and nulligravid women. However, in Colombia, we detected antibodies against multiple constructs of VAR2CSA among men and children with acute P. falciparum and Plasmodium vivax infection. The majority of men and children (>60%) had high levels of IgGs against three recombinant domains of VAR2CSA: DBL5ε, DBL3X, and ID1-ID2. Surprisingly, these antibodies were observed only in pregnant women, men, and children exposed either to P. falciparum or to P. vivax. Moreover, the anti-VAR2CSA antibodies are of high avidity and efficiently inhibit adherence of infected red blood cells to chondroitin sulfate A in vitro, suggesting that they are specific and functional. These unexpected results suggest that there may be genotypic or phenotypic differences in the parasites of this region or in the host response to either P. falciparum or P. vivax infection outside pregnancy. These findings may hold significant clinical relevance to the pathophysiology and outcome of malaria infections in this region.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24686068      PMCID: PMC4019168          DOI: 10.1128/IAI.01594-14

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  47 in total

1.  Antibody responses and avidity of naturally acquired anti-Plasmodium vivax Duffy binding protein (PvDBP) antibodies in individuals from an area with unstable malaria transmission.

Authors:  Sedigheh Zakeri; Laleh Babaeekhou; Akram Abouie Mehrizi; Maryam Abbasi; Navid Dinparast Djadid
Journal:  Am J Trop Med Hyg       Date:  2011-06       Impact factor: 2.345

2.  Diagnosis of gestational, congenital, and placental malaria in Colombia: comparison of the efficacy of microscopy, nested polymerase chain reaction, and histopathology.

Authors:  Ivón M Campos; Mary L Uribe; Carolina Cuesta; Alexander Franco-Gallego; Jaime Carmona-Fonseca; Amanda Maestre
Journal:  Am J Trop Med Hyg       Date:  2011-06       Impact factor: 2.345

3.  Association between naturally acquired antibodies to erythrocyte-binding antigens of Plasmodium falciparum and protection from malaria and high-density parasitemia.

Authors:  Jack S Richards; Danielle I Stanisic; Freya J I Fowkes; Livingstone Tavul; Elijah Dabod; Jennifer K Thompson; Sanjeev Kumar; Chetan E Chitnis; David L Narum; Pascal Michon; Peter M Siba; Alan F Cowman; Ivo Mueller; James G Beeson
Journal:  Clin Infect Dis       Date:  2010-10-15       Impact factor: 9.079

4.  High efficacy of anti DBL4ɛ-VAR2CSA antibodies in inhibition of CSA-binding Plasmodium falciparum-infected erythrocytes from pregnant women.

Authors:  Pamela A Magistrado; Daniel Minja; Justin Doritchamou; Nicaise Tuikue Ndam; Davis John; Christentze Schmiegelow; Achille Massougbodji; Madeleine Dahlbäck; Sisse B Ditlev; Vera V Pinto; Mafalda Resende; John Lusingu; Thor G Theander; Ali Salanti; Morten A Nielsen
Journal:  Vaccine       Date:  2010-11-12       Impact factor: 3.641

5.  The NTS-DBL2X region of VAR2CSA induces cross-reactive antibodies that inhibit adhesion of several Plasmodium falciparum isolates to chondroitin sulfate A.

Authors:  Pascal Bigey; Sédami Gnidehou; Justin Doritchamou; Mickael Quiviger; Firmine Viwami; Aude Couturier; Ali Salanti; Morten A Nielsen; Daniel Scherman; Philippe Deloron; Nicaise Tuikue Ndam
Journal:  J Infect Dis       Date:  2011-10-01       Impact factor: 5.226

6.  Evasion of immunity to Plasmodium falciparum malaria by IgM masking of protective IgG epitopes in infected erythrocyte surface-exposed PfEMP1.

Authors:  Lea Barfod; Michael B Dalgaard; Suzan T Pleman; Michael F Ofori; Richard J Pleass; Lars Hviid
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-11       Impact factor: 11.205

7.  Plasmodium falciparum population dynamics in a cohort of pregnant women in Senegal.

Authors:  Juliette Guitard; Pernille Andersen; Caroline Ermont; Sédami Gnidehou; Nadine Fievet; Ole Lund; Philippe Deloron; Nicaise Tuikue Ndam
Journal:  Malar J       Date:  2010-06-16       Impact factor: 2.979

8.  Insight into antigenic diversity of VAR2CSA-DBL5ε domain from multiple Plasmodium falciparum placental isolates.

Authors:  Sédami Gnidehou; Leon Jessen; Stéphane Gangnard; Caroline Ermont; Choukri Triqui; Mickael Quiviger; Juliette Guitard; Ole Lund; Philippe Deloron; Nicaise Tuikue Ndam
Journal:  PLoS One       Date:  2010-10-01       Impact factor: 3.240

9.  Chondroitin sulphate A (CSA)-binding of single recombinant Duffy-binding-like domains is not restricted to Plasmodium falciparum Erythrocyte Membrane Protein 1 expressed by CSA-binding parasites.

Authors:  Mafalda Resende; Sisse B Ditlev; Morten A Nielsen; Sabrina Bodevin; Silas Bruun; Vera V Pinto; Henrik Clausen; Louise Turner; Thor G Theander; Ali Salanti; Madeleine Dahlbäck
Journal:  Int J Parasitol       Date:  2009-03-24       Impact factor: 3.981

10.  Multiplexed real-time PCR assay for discrimination of Plasmodium species with improved sensitivity for mixed infections.

Authors:  Sandra E Shokoples; Momar Ndao; Kinga Kowalewska-Grochowska; Stephanie K Yanow
Journal:  J Clin Microbiol       Date:  2009-02-25       Impact factor: 5.948

View more
  12 in total

1.  Cross-Species Immune Recognition Between Plasmodium vivax Duffy Binding Protein Antibodies and the Plasmodium falciparum Surface Antigen VAR2CSA.

Authors:  Sédami Gnidehou; Catherine J Mitran; Eliana Arango; Shanna Banman; Angie Mena; Evelyn Medawar; Barbara A S Lima; Justin Doritchamou; Jahanara Rajwani; Albert Jin; Kenneth Gavina; Francis Ntumngia; Patrick Duffy; David Narum; Nicaise Tuikue Ndam; Morten A Nielsen; Ali Salanti; Flora S Kano; Luzia H Carvalho; John H Adams; Amanda Maestre; Michael F Good; Stephanie K Yanow
Journal:  J Infect Dis       Date:  2019-01-01       Impact factor: 5.226

2.  Parity-dependent recognition of DBL1X-3X suggests an important role of the VAR2CSA high-affinity CSA-binding region in the development of the humoral response against placental malaria.

Authors:  Sébastien Dechavanne; Anand Srivastava; Stéphane Gangnard; Sofia Nunes-Silva; Célia Dechavanne; Nadine Fievet; Philippe Deloron; Arnaud Chêne; Benoît Gamain
Journal:  Infect Immun       Date:  2015-03-30       Impact factor: 3.441

3.  Burkitt lymphoma expresses oncofetal chondroitin sulfate without being a reservoir for placental malaria sequestration.

Authors:  Mette Ø Agerbaek; Marina A Pereira; Thomas M Clausen; Caroline Pehrson; Htoo Zarni Oo; Charlotte Spliid; Jamie R Rich; Vincent Fung; Francis Nkrumah; Janet Neequaye; Robert J Biggar; Steven J Reynolds; Giovanna Tosato; Sheeja T Pullarkat; Leona W Ayers; Thor G Theander; Mads Daugaard; Kishor Bhatia; Morten A Nielsen; Sam M Mbulaiteye; Ali Salanti
Journal:  Int J Cancer       Date:  2017-02-06       Impact factor: 7.396

4.  Clinical Outcomes of Submicroscopic Infections and Correlates of Protection of VAR2CSA Antibodies in a Longitudinal Study of Pregnant Women in Colombia.

Authors:  Kenneth Gavina; Sedami Gnidehou; Eliana Arango; Chloe Hamel-Martineau; Catherine Mitran; Olga Agudelo; Carolina Lopez; Aisha Karidio; Shanna Banman; Jaime Carmona-Fonseca; Ali Salanti; Nicaise Tuikue Ndam; Michael Hawkes; Amanda Maestre; Stephanie K Yanow
Journal:  Infect Immun       Date:  2018-03-22       Impact factor: 3.441

5.  Comparison of the specificity of antibodies to VAR2CSA in Cameroonian multigravidae with and without placental malaria: a retrospective case-control study.

Authors:  Anna Babakhanyan; Rui Fang; Andrew Wey; Ali Salanti; Grace Sama; Canisia Efundem; Robert J I Leke; John J Chen; Rose G F Leke; Diane W Taylor
Journal:  Malar J       Date:  2015-12-01       Impact factor: 2.979

6.  Antibody responses to the full-length VAR2CSA and its DBL domains in Cameroonian children and teenagers.

Authors:  Barriere A Y Fodjo; Njika Atemnkeng; Livo Esemu; Emile K Yuosembom; Isabella A Quakyi; Viviane H M Tchinda; Joseph Smith; Ali Salanti; Jude Bigoga; Diane W Taylor; Rose G F Leke; Anna Babakhanyan
Journal:  Malar J       Date:  2016-11-04       Impact factor: 2.979

Review 7.  Designing a VAR2CSA-based vaccine to prevent placental malaria.

Authors:  Michal Fried; Patrick E Duffy
Journal:  Vaccine       Date:  2015-11-26       Impact factor: 3.641

8.  IgG Responses to the Plasmodium falciparum Antigen VAR2CSA in Colombia Are Restricted to Pregnancy and Are Not Induced by Exposure to Plasmodium vivax.

Authors:  Mary Lopez-Perez; Mads Delbo Larsen; Rafael Bayarri-Olmos; Paulina Ampomah; Liz Stevenson; Myriam Arévalo-Herrera; Sócrates Herrera; Lars Hviid
Journal:  Infect Immun       Date:  2018-07-23       Impact factor: 3.441

9.  Differential recognition of terminal extracellular Plasmodium falciparum VAR2CSA domains by sera from multigravid, malaria-exposed Malian women.

Authors:  Mark A Travassos; Drissa Coulibaly; Jason A Bailey; Amadou Niangaly; Matthew Adams; Myaing M Nyunt; Amed Ouattara; Kirsten E Lyke; Matthew B Laurens; Jozelyn Pablo; Algis Jasinskas; Rie Nakajima; Andrea A Berry; Shannon Takala-Harrison; Abdoulaye K Kone; Bourema Kouriba; J Alexandra Rowe; Ogobara K Doumbo; Mahamadou A Thera; Miriam K Laufer; Philip L Felgner; Christopher V Plowe
Journal:  Am J Trop Med Hyg       Date:  2015-04-27       Impact factor: 2.345

10.  mSphere of Influence: Going Native, or the Risk of Overreliance on Recombinant Antigens.

Authors:  Mary Lopez-Perez
Journal:  mSphere       Date:  2020-04-08       Impact factor: 4.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.